<?xml version="1.0"?>
<rss version="2.0">
   <channel>
      <title>DRUG STUDY by Angel Athea Santos</title>
      <link>https://padlet.com/santosangelathea/qituhc4u670umaeb</link>
      <description>METOPROLOL AND NYTROGLYCERIN</description>
      <language>en-us</language>
      <pubDate>2021-09-16 17:28:28 UTC</pubDate>
      <lastBuildDate>2023-02-24 06:41:50 UTC</lastBuildDate>
      <webMaster>hello@padlet.com</webMaster>
      <image>
         <url>https://padlet.net/icons/png/1f973.png</url>
      </image>
      <item>
         <title>Metoprolol</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746644369</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://www.daralteb.net/wp-content/uploads/2018/03/3-31.jpg" />
         <pubDate>2021-09-16 17:37:43 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746644369</guid>
      </item>
      <item>
         <title>Brand Name</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746653145</link>
         <description><![CDATA[<div>•	Lopresor<br>•	Nu-Metop<br>•	Toprol XL</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 17:41:48 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746653145</guid>
      </item>
      <item>
         <title>Drug Classification</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746673366</link>
         <description><![CDATA[<div>•	Antihypertensive&nbsp;<br>•	Antianginal<br>•	β1-Blocker</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 17:50:57 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746673366</guid>
      </item>
      <item>
         <title>Mechanism of Action</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746693289</link>
         <description><![CDATA[<div>Lowers B/P by β-blocking effects; reduces elevated renin plasma levels; blocks β2- adrenergic receptors in bronchial, vascular smooth muscle only at high doses; negative chronotropic effect</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:00:43 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746693289</guid>
      </item>
      <item>
         <title>Therapeutic Effect</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746712739</link>
         <description><![CDATA[<div>Slows heart rate, decreases cardiac output, reduces B/P. Decreases myocardial ischemia severity.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:10:04 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746712739</guid>
      </item>
      <item>
         <title>Stock Dosage</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746718215</link>
         <description><![CDATA[<div>•	Injection Solution: 1 mg/mL.&nbsp;<br>•	Tablets (Immediate-Release): 25 mg, 50 mg, 100 mg.&nbsp;<br>•	Tablets (Extended-Release): 25 mg, 50 mg, 100 mg,&nbsp;<br>&nbsp; &nbsp;200 mg.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:12:53 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746718215</guid>
      </item>
      <item>
         <title>Indication</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746721651</link>
         <description><![CDATA[<div>To relieve mild to moderate pain from headache, muscle ache, backache, minor arthritis, common cold, toothache, or menstrual cramps; to reduce fever.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:14:48 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746721651</guid>
      </item>
      <item>
         <title>Contraindications</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746724439</link>
         <description><![CDATA[<div>•	Hypersensitivity to metoprolol. (Immediate-Release):&nbsp;<br>•	MI: Severe sinus bradycardia, MI with heart rate less&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;than 45 beats/min or systolic B/P less than 100 mmHg,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;moderate to severe HF, significant first-degree heart&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;block, second- or third-degree heart block.&nbsp;<br>•	(Immediate-Release): HTN/Angina: Sinus bradycardia,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;second- or third-degree heart block, cardiogenic&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;shock, overt HF, sick sinus syndrome (except with&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;pacemaker), severe peripheral arterial disease, &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;pheochromocytoma. (Extended-Release): Severe&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;bradycardia, secondor third-degree heart block, &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;cardiogenic shock, decompensated HF, sick sinus&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;syndrome (except with functioning pacemaker).&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Hypersensitivity to acetaminophen.&nbsp;<br>•	(Ofirmev): severe hepatic impairment or severe active&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;liver disease. &nbsp;<br>•	Cautions: Arterial obstruction, bronchospastic disease,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;hepatic impairment, peripheral vascular disease,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;hyperthyroidism, diabetes mellitus, myasthenia gravis,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;psychiatric disease, history of severe anaphylaxis to&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; allergens.&nbsp;<br>•	(Extended-Release): Compensated HF.&nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:16:14 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746724439</guid>
      </item>
      <item>
         <title>Side Effects</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746729299</link>
         <description><![CDATA[<div>•	Frequent: Diminished sexual function, drowsiness,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; insomnia, unusual fatigue/weakness.&nbsp;<br>•	Occasional: Anxiety, diarrhea, constipation, nausea,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;vomiting, nasal congestion, abdominal discomfort,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;dizziness, difficulty breathing, cold hands/feet.&nbsp;<br>•	Rare: Altered taste, dry eyes, nightmares, paresthesia,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; allergic reaction (rash, pruritus).</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:18:45 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746729299</guid>
      </item>
      <item>
         <title>Adverse Effects</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746736597</link>
         <description><![CDATA[<div>Overdose may produce profound bradycardia, hypotension, bronchospasm. Abrupt withdrawal may result in diaphoresis, palpitations, headache, tremulousness, exacerbation of angina, MI, ventricular arrhythmias. May precipitate HF, MI in pts with heart disease, thyroid storm in those with thyrotoxicosis, peripheral ischemia in those with existing peripheral vascular disease. Hypoglycemia may occur in pts with previously controlled diabetes (may mask signs of hypoglycemia).&nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:22:43 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746736597</guid>
      </item>
      <item>
         <title>Nursing interventions</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746738212</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://media4.giphy.com/media/OBPQz329RdKXS/giphy.gif" />
         <pubDate>2021-09-16 18:23:35 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746738212</guid>
      </item>
      <item>
         <title>Assessment</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746741928</link>
         <description><![CDATA[<div>•	Assess baseline renal function, LFT.&nbsp;<br>•	Assess B/P, apical pulse immediately before drug&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; administration (if pulse is 60/min or less or systolic B/P&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; is less than 90 mm Hg, withhold medication, contact&nbsp; &nbsp; &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; physician).&nbsp;<br>•	Antianginal: Record onset, type (sharp, dull,&nbsp; &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;squeezing), radiation, location, intensity, duration of&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;anginal pain, precipitating factors (exertion, emotional&nbsp; &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;stress).<br>•	If given for analgesia, assess onset, type, location,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;duration of pain.&nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:25:31 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746741928</guid>
      </item>
      <item>
         <title>Intervention/evaluation </title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746750912</link>
         <description><![CDATA[<div>•	Measure B/P near end of dosing interval (determines&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; whether B/P is controlled throughout day).&nbsp;<br>•	Monitor B/P for hypotension, respiration for shortness&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; of breath.&nbsp;<br>•	Assess pulse for quality, rate, rhythm.&nbsp;<br>•	Assess for evidence of HF: dyspnea (esp. on exertion,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; lying down), night cough, peripheral edema, distended&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; neck veins.&nbsp;<br>•	Monitor I&amp;O (increased weight, decreased urinary&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;output may indicate HF).&nbsp;<br>•	Therapeutic response to hypertension noted in 1–2&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;wks.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:30:13 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746750912</guid>
      </item>
      <item>
         <title>Patient &amp; Family Teaching</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746753690</link>
         <description><![CDATA[<div>• Do not abruptly discontinue medication.&nbsp;<br>• Compliance with therapy regimen is essential to&nbsp; &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;control hypertension, arrhythmias.&nbsp;<br>• If dose is missed, take next scheduled dose (do not&nbsp; &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp;double dose).&nbsp;<br>• Go from lying to standing slowly.&nbsp;<br>• Report excessive fatigue, dizziness.&nbsp;<br>• Avoid tasks that require alertness, motor skills until &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; response to drug is established.&nbsp;<br>• Do not use nasal decongestants, OTC cold &nbsp;<br>&nbsp; &nbsp;preparations (stimulants) without physician approval.&nbsp;<br>• Monitor B/P, pulse before taking medication.&nbsp;<br>• Restrict salt, alcohol intake.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:31:40 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746753690</guid>
      </item>
      <item>
         <title>Nitroglycerin</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746774127</link>
         <description><![CDATA[]]></description>
         <enclosure url="http://www.eyecareandcure.com/core/media/media.nl?id=1531&amp;c=723462&amp;h=d5a74fb75bee1df8ace7" />
         <pubDate>2021-09-16 18:42:33 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746774127</guid>
      </item>
      <item>
         <title>Brand Name </title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746775743</link>
         <description><![CDATA[<div>•	Nitrojet &nbsp;<br>•	Nitronal<br>•	Nitrostat</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:43:28 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746775743</guid>
      </item>
      <item>
         <title>Drug Classification</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746777733</link>
         <description><![CDATA[<div>•	Coronary vasodilator<br>•	Antianginal&nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:44:38 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746777733</guid>
      </item>
      <item>
         <title>Mechanism of Action</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746780058</link>
         <description><![CDATA[<div>•	Decreases preload and afterload, which are responsible&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; for decreasing left ventricular end-diastolic pressure,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; systemic vascular resistance; dilates coronary arteries,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; improves blood flow through coronary vasculature,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; dilates arterial and venous beds systemically.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:46:03 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746780058</guid>
      </item>
      <item>
         <title>Stock Dosage</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746787494</link>
         <description><![CDATA[<div>•	Infusion, Pre-Mix: 25 mg/250 mL, 50 mg/500 mL,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; 50 mg/250 mL, 100 mg/250 mL.&nbsp;<br>•	Injection, Solution: 5 mg/mL.&nbsp;<br>•	Ointment (Nitro-Bid): 2%.&nbsp;<br>•	Ointment, Rectal (Rectiv): 0.4%.&nbsp;<br>•	Translingual Spray: 0.4 mg/spray.&nbsp;<br>•	Transdermal Patch: 0.1 mg/hr, 0.2 mg/hr, 0.4 mg/hr,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;    0.6 mg/hr.&nbsp;<br>•	Capsules, Extended-Release: 2.5 mg, 6.5 mg, 9 mg.&nbsp;<br>•	Tablets, Sublingual: 0.4 mg.Capsules: 75 mg, 150 mg,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;300 mg.&nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:50:07 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746787494</guid>
      </item>
      <item>
         <title>Indication</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746792575</link>
         <description><![CDATA[<div>•	Treatment/prevention of angina pectoris. Extended-<br>&nbsp; &nbsp; &nbsp; &nbsp; release, topical forms used for prophylaxis, long-term&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; angina management. IV form used in treatment of HF,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; acute MI, perioperative hypertension, induction of&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;intraoperative hypotension.&nbsp;<br>•	Rectiv: Treatment of moderate to severe pain&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; associated with chronic anal fissure.<br>•	OFF-LABEL: Short-term management of pulmonary&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;hypertension, esophageal spastic disorders, uterine&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;relaxation, treatment of sympathomimetic vasopressor&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;extravasation.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:52:53 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746792575</guid>
      </item>
      <item>
         <title>Contraindications</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746795155</link>
         <description><![CDATA[<div>•	Hypersensitivity to nitroglycerin. Allergy to adhesives (<br>&nbsp; &nbsp; &nbsp; &nbsp; transdermal); increased ICP; severe anemia;&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; concurrent use of sildenafil, tadalafil, vardenafil (PDE5&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;inhibitors).&nbsp;<br>•	(Additional)IV: Restrictive cardiomyopathy, pericardial&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;tamponade, constrictive pericarditis.&nbsp;<br>•	Sublingual, Rectal: Increased intracranial pressure,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;severe anemia.<br>•	Cautions: Blood volume depletion, severe hypotension (systolic B/P less than 90 mm Hg), bradycardia (less than 50 beats/min), inferior wall MI and suspected right ventricular involvement. &nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:54:19 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746795155</guid>
      </item>
      <item>
         <title>Side Effects</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746800096</link>
         <description><![CDATA[<div>•	Frequent: Headache (possibly severe; occurs mostly in&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; early therapy, diminishes rapidly in intensity, usually&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; disappears during continued treatment), transient&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; flushing of face/neck, dizziness (esp. if pt is standing&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;immobile or is in a warm environment), weakness,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;orthostatic hypotension.<br>•	Sublingual: Burning, tingling sensation at oral point of&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;dissolution. &nbsp;<br>•	Ointment: Erythema, pruritus.<br>•	Occasional: GI upset.<br>•	Transdermal: Contact dermatitis. &nbsp;</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:57:03 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746800096</guid>
      </item>
      <item>
         <title>Adverse Effects</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746801922</link>
         <description><![CDATA[<div>Discontinue drug if blurred vision, dry mouth occurs. Severe orthostatic hypotension may occur, manifested by syncope, pulselessness, cold/clammy skin, diaphoresis. Tolerance may occur with repeated, prolonged therapy; minor tolerance may occur with intermittent use of sublingual tablets. High doses tend to produce severe headache.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 18:58:10 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746801922</guid>
      </item>
      <item>
         <title>Nursing Interventions</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746803231</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://media1.giphy.com/media/MBm5UlDeDNKVi/giphy.gif" />
         <pubDate>2021-09-16 18:58:56 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746803231</guid>
      </item>
      <item>
         <title>Assessment</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746804863</link>
         <description><![CDATA[<div>•	Record onset, type (sharp, dull, squeezing), radiation,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;location, intensity, duration of anginal pain;&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;precipitating factors (exertion, emotional stress).&nbsp;<br>•	Assess B/P, apical pulse before administration and &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; periodically following dose.&nbsp;<br>•	Pt must have continuous EKG monitoring for IV&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;administration.&nbsp;<br>•	Rule out rightsided MI, if applicable (may precipitate&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; life-threatening hypotension).&nbsp;<br>•	Receive full medication history, and screen for&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;interactions, esp. use of PDE5 inhibitors.&nbsp;<br>•	Question medical history and screen for&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;contraindications.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 19:00:00 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746804863</guid>
      </item>
      <item>
         <title>Intervention/evaluation </title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746806152</link>
         <description><![CDATA[<div>•	Monitor B/P, heart rate.&nbsp;<br>•	Assess for facial, neck flushing.&nbsp;<br>•	Cardioverter/defibrillator must not be discharged through&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;paddle electrode overlying nitroglycerin (transdermal,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;ointment) system (may cause burns to pt or damage to&nbsp;<br>         paddle via electrical arcing).&nbsp;<br>•	Consider NS boluses for hypotension.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 19:00:36 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746806152</guid>
      </item>
      <item>
         <title>Patient &amp; Family Teaching</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746810227</link>
         <description><![CDATA[<div>•	Go from lying to standing slowly.&nbsp;<br>•	Take oral form on empty stomach (however, if&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;headache occurs during therapy, take medication with&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;meals).&nbsp;<br>•	Use spray only when lying down.&nbsp;<br>•	Dissolve sublingual tablet under tongue; do not&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;swallow.&nbsp;<br>•	Take at first sign of angina.&nbsp;<br>•	May take additional dose q5min if needed up to a total &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; of 3 doses.&nbsp;<br>•	If not relieved within 5 min, contact physician or&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;immediately go to emergency room.&nbsp;<br>•	Do not change brands.&nbsp;<br>•	Keep container away from heat, moisture.&nbsp;<br>•	Do not inhale lingual aerosol but spray onto or under&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; tongue (avoid swallowing after spray is administered).&nbsp;<br>•	Expel from mouth any remaining lingual, sublingual,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;intrabuccal tablet after pain is completely relieved.&nbsp;<br>•	Place transmucosal tablets under upper lip or buccal&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;pouch (between cheek and gum); do not&nbsp; &nbsp;&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;chew/swallow tablet.&nbsp;<br>•	Avoid alcohol (intensifies hypotensive effect). If&nbsp; &nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; alcohol is ingested soon after taking nitroglycerin,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; possible acute hypotensive episode (marked drop in&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; B/P, vertigo, diaphoresis, pallor) may occur.&nbsp;<br>•	Do not use within 48 hrs of sildenafil, tadalafil,&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;vardenafil (PDE5 inhibitors); may cause acute&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; hypotensive episode.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 19:03:16 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746810227</guid>
      </item>
      <item>
         <title>References:</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746812007</link>
         <description><![CDATA[<div>Hodgson, B. B., &amp; Kizior, R. J. (2019). Saunders Nursing Drug&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Handbook 2019. St. Louis: Elsevier.<br><br>Skidmore-Roth, L. (2019). Mosby's 2019 Nursing Drug&nbsp;<br>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Reference.</div>]]></description>
         <enclosure url="" />
         <pubDate>2021-09-16 19:04:23 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746812007</guid>
      </item>
      <item>
         <title>Drug Study Paper</title>
         <author>santosangelathea</author>
         <link>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746827368</link>
         <description><![CDATA[]]></description>
         <enclosure url="https://padlet-uploads.storage.googleapis.com/1350782017/d485ad67af054f5c806ba1aa7e3ec567/SANTOS__ANGEL_ATHEA_E___DRUG_STUDY_MI.pdf" />
         <pubDate>2021-09-16 19:14:15 UTC</pubDate>
         <guid>https://padlet.com/santosangelathea/qituhc4u670umaeb/wish/1746827368</guid>
      </item>
   </channel>
</rss>
